✦ LIBER ✦

Screening for Down syndrome at 14 weeks of pregnancy

✍ Scribed by N. J. Wald; H. C. Watt; J. E. Haddow; G. J. Knight

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 32 KB
Volume: 18
Category: Article
ISSN: 0197-3851
DOI: 10.1002/(sici)1097-0223(199803)18:3<291::aid-pd244>3.0.co;2-8

No coin nor oath required. For personal study only.

✦ Synopsis

To investigate whether statistical parameters used in Down syndrome screening between 15 and 22 weeks of pregnancy can be used at 14 weeks, we assayed alpha-fetoprotein (AFP), unconjugated oestriol (uE 3 ), total human chorionic gonadotrophin (hCG), free -hCG, free -hCG, and inhibin-A in 16 pregnancies with Down syndrome in the 14th week of pregnancy and expressed values in multiples of the normal median. The median and standard deviation values for these 16 pregnancies were not materially different from those published for 15-22 weeks. It is reasonable, therefore, to offer Down syndrome screening using these markers starting at 14 completed weeks of pregnancy instead of 15 weeks. It needs to be recognized, however, that serum AFP measurement for neural tube defect screening is less effective at this time than between 16 and 18 weeks of pregnancy. 1998 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

MULTIPLE MARKER SCREENING FOR DOWN SYNDR

MULTIPLE MARKER SCREENING FOR DOWN SYNDROME IN TWIN PREGNANCIES

✍ LOUIS M. NEVEUX; GLENN E. PALOMAKI; GEORGE J. KNIGHT; JAMES E. HADDOW 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 1 views

This study documents the screening performance, in practice, of a published protocol for interpreting secondtrimester Down syndrome risk in twin pregnancies, using maternal serum biochemical markers. Within a cohort of 35 150 pregnancies, 410 twin pregnancies were identified. The rate of twinning wa

MATERNAL SERUM SCREENING FOR FETAL DOWN

MATERNAL SERUM SCREENING FOR FETAL DOWN SYNDROME IN IVF PREGNANCIES

✍ L. S. M. RIBBERT; L. H. KORNMAN; B. T. H. M. DE WOLF; A. H. M. SIMONS; C. A. M. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB 👁 1 views

To assess the influence of in vitro fertilization (IVF) on maternal serum human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP), the maternal serum hCG and AFP values were studied in 67 IVF pregnancies and compared with the results of a control group of 4732 spontaneously conceiving patien

SCREENING FOR DOWN SYNDROME PREGNANCY US

SCREENING FOR DOWN SYNDROME PREGNANCY USING β-CORE FRAGMENT: PROSPECTIVE STUDY

✍ TAICHI ISOZAKI; GLENN E. PALOMAKI; RAY O. BAHADO-SINGH; LAURENCE A. COLE 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Two recent publications by Cuckle et al., and one each by Canick et al. and Kellner et al., describe the use of urine beta-core fragment measurements as a screening test for Down syndrome pregnancies. Median levels of over 5.4 MOM were reported for cases of Down syndrome, with an over 72 per cent de

URINARY β-CORE hCG: SCREENING FOR ANEUPL

URINARY β-CORE hCG: SCREENING FOR ANEUPLOIDIES IN EARLY PREGNANCY (11–14 WEEKS' GESTATION)

✍ M. C. M. MACINTOSH; K. H. NICOLAIDES; P. NOBLE; T. CHARD; L. GUNN; R. ILES 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Initial studies at 17-22 weeks' gestation evaluating urinary -core human chorionic gonadotrophin (hCG) as a marker for Down's syndrome had suggested that it may have more potential than its serum counterpart. This study measured maternal urinary -core-hCG and creatinine at 11-14 weeks' gestation in

Maternal serum screening for Down syndro

Maternal serum screening for Down syndrome in pregnancies conceived by intra-uterine insemination

✍ Te-Yao Hsu; Chia-Yu Ou; Jenn-Jeih Hsu; Fu-Tsai Kung; Shiun-Young Chang; Yung-Kue 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

The purpose of our study was to assess the influence of intra-uterine insemination (IUI) on the results of maternal serum Down syndrome screening. 43 women with IUI pregnancies and 4507 healthy women who conceived were studied. Ovulation in IUI pregnancies was induced by clomiphene and/or human meno

Serum screening for Down syndrome and ad

Serum screening for Down syndrome and adverse pregnancy outcomes: a case-controlled study

✍ Robert Ogle; Eric Jauniaux; Gurmit S. Pahal; Elissa Dell; Ann Sheldrake; Charles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

The relationship between adverse perinatal outcomes in women with false positive biochemical screening test for Down syndrome was investigated in a retrospective case-controlled study. A cohort of 4000 women who booked for routine antenatal care and opted for biochemical screening over a 22 month pe